MIR27A rs895819 TC genotype increases risk of fluoropyrimidine-induced severe toxicity independently of DPYD variations

被引:2
作者
Ragia, Georgia [1 ,2 ]
Biziota, Eirini [3 ]
Koukaki, Triantafyllia [3 ]
Amarantidis, Kyriakos [3 ]
Manolopoulos, Vangelis G. [1 ,2 ,4 ]
机构
[1] Democritus Univ Thrace, Med Sch, Lab Pharmacol, Alexandroupolis 68100, Greece
[2] Individualised Med & Pharmacol Res Solut Ctr IMPRe, Alexandroupolis, Greece
[3] Democritus Univ Thrace, Univ Gen Hosp Alexandroupolis, Med Sch, Dept Med Oncol, Alexandroupolis 68100, Greece
[4] Acad Gen Hosp Alexandroupolis, Clin Pharmacol Unit, Alexandroupolis, Greece
关键词
5-fluorouracil; capecitabine; chemotherapy; DPYD; fluoropyrimidines; MIR27A; overdominance; pharmacogenomics; rs895819; toxicity; GASTRIC-CANCER SUSCEPTIBILITY; EXPRESSION; MICRORNAS; MIR-27A; VARIANT; POLYMORPHISMS; CONTRIBUTE;
D O I
10.2217/pgs-2023-0223
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: MicroRNA 27a (miR-27a) regulates post-transcriptionally DPD activity. We have analyzed the association of MIR27A rs895819T>C variation, that modulates miR-27a expression, with FP-induced toxicity. Materials & methods: MIR27A rs895819T>C genotyping was conducted by TaqMan allelic discrimination assay in 313 FP-treated cancer patients. Results: In overdominance (TC vs TT + CC), TC genotype was associated with grade 3-4 toxicity (p = 0.002), any grade toxicity (p = 0.052), and delayed drug administration or therapy discontinuation (p = 0.038). Odds of grade 3-4 toxicity were increased by both DPYD deficiency (OR: 8.923; p = 0.006) and MIR27A rs895819 TC genotype (OR: 3.865; p = 0.002). Conclusion: MIR27A rs895819 TC genotype is an independent risk factor for fluoropyrimidine-associated toxicity in the Greek population. Thus, MIR27A rs895819TC patients can be closely monitored for fluoropyrimidine-induced severe toxicity.
引用
收藏
页数:10
相关论文
共 24 条
  • [1] Overdominance in the human genome and olfactory receptor activity
    Alonso, Santos
    Lopez, Saioa
    Izagirre, Neskuts
    de la Rua, Concepcion
    [J]. MOLECULAR BIOLOGY AND EVOLUTION, 2008, 25 (05) : 997 - 1001
  • [2] Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy
    Amstutz, Ursula
    Offer, Steven M.
    Sistonen, Johanna
    Joerger, Markus
    Diasio, Robert B.
    Largiader, Carlo R.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (09) : 2038 - 2044
  • [3] [Anonymous], 2020, EMA Recommendations on DPD Testing Prior to Treatment with Fluorouracil, Capecitabine, Tegafur and Flucytosine
  • [4] Association between a functional variant in microRNA-27a and susceptibility to colorectal cancer in a Chinese Han population
    Cao, Y.
    Hu, J.
    Fang, Y.
    Chen, Q.
    Li, H.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) : 7420 - 7427
  • [5] Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk
    De Mattia, Elena
    Silvestri, Marco
    Polesel, Jerry
    Ecca, Fabrizio
    Mezzalira, Silvia
    Scarabel, Lucia
    Zhou, Yitian
    Roncato, Rossana
    Lauschke, Volker M.
    Calza, Stefano
    Spina, Michele
    Puglisi, Fabio
    Toffoli, Giuseppe
    Cecchin, Erika
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 154
  • [6] DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan
    Falvella, Felicia Stefania
    Cheli, Stefania
    Martinetti, Antonia
    Mazzali, Cristina
    Iacovelli, Roberto
    Maggi, Claudia
    Gariboldi, Manuela
    Pierotti, Marco Alessandro
    Di Bartolomeo, Maria
    Sottotetti, Elisa
    Mennitto, Roberta
    Bossi, Ilaria
    de Braud, Filippo
    Clementi, Emilio
    Pietrantonio, Filippo
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 581 - 588
  • [7] The pre-mir-27a variant rs895819 may contribute to type 2 diabetes mellitus susceptibility in an Iranian cohort
    Ghaedi, H.
    Tabasinezhad, M.
    Alipoor, B.
    Shokri, F.
    Movafagh, A.
    Mirfakhraie, R.
    Omrani, M. D.
    Masotti, A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) : 1187 - 1193
  • [8] Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues
    Hirota, Takeshi
    Date, Yuko
    Nishibatake, Yu
    Takane, Hiroshi
    Fukuoka, Yasushi
    Taniguchi, Yuuji
    Burioka, Naoto
    Shimizu, Eiji
    Nakamura, Hiroshige
    Otsubo, Kenji
    Ieiri, Ichiro
    [J]. LUNG CANCER, 2012, 77 (01) : 16 - 23
  • [9] Ioannou Charalampia, 2022, Drug Metabolism and Personalized Therapy, V37, P323, DOI 10.1515/dmpt-2021-0219
  • [10] Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine based chemotherapy toxicity
    Ioannou, Charalampia
    Ragia, Georgia
    Balgkouranidou, Ioanna
    Xenidis, Nikolaos
    Amarantidis, Kyriakos
    Koukaki, Triantafyllia
    Biziota, Eirini
    Kakolyris, Stylianos
    Manolopoulos, Vangelis G.
    [J]. PHARMACOGENOMICS, 2021, 22 (11) : 669 - 680